Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)[E7]

De gegevens van de aankondiging staan zoals de bron ze publiceerde. De feiten en eisen die wij eruit halen zijn in het Engels.

• Open voorSmall and medium firms, Startups. Door SLETOR ingedeeld op basis van de woorden in de vermelding.

• RisicoApplications have not opened. The funder can change the details and dates before they do.[E4]
• RisicoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E4]
• OnbekendNo closing date we could read. Some grants are open all year, so check the funder's page.
• OnbekendThe listing does not say how much funding is available.
• OnbekendWe read the funder's listing, not the full guidance or application forms.

1. Voor het eerst gezien · 28 okt 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Bronrecord: Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726)

Elk gegeven op deze pagina komt uit de vermelding van de financier. Elke regel toont het record en het veld waaruit het is gelezen.

1. E1

   Assistance listing (CFDA) 93.395, 93.394.

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /cfdaList, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

2. E2

   The funder is National Institutes of Health.

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /agency, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

3. E3

   The funder is a US federal agency.

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /agencyCode, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

4. E4

   This is a forecast: the agency expects to publish this grant.

   “forecasted”

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /oppStatus, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

5. E5

   The notice was published on 16 Jun 2025.

   “2025-06-16”

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /openDate, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

6. E6

   Grants.gov gives the status as forecasted.

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /oppStatus, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

7. E7

   The notice is titled "Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optiona…".

   “Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)”

   Uit Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge A… (ID 359726), veld /title, gelezen 29 okt 2026, 03:42 UTC · bron ↗ (opent in nieuw tabblad)

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Datalicentie: Grants.gov API terms of use ↗ (opent in nieuw tabblad). Persoonlijke contactgegevens uit aankondigingen worden niet bewaard of getoond.